| 96 |
Axonal sodium channel modulation leading to acute mortality |
Kellie Fay |
BY-SA |
598: modulation, sodium channel
|
351: Increased Mortality
|
|
|
| 97 |
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline |
Kellie Fay |
BY-SA |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)
|
2 AOs
|
|
|
| 99 |
Histamine (H2) receptor antagonism leading to reduced survival |
Kellie Fay |
BY-SA |
638: Antagonism, Histamine Receptor (H2)
|
2 AOs
|
|
|
| 100 |
Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 101 |
Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 102 |
Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 103 |
Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 104 |
Altered ion channel activity leading impaired heart function |
Undefined |
BY-SA |
697: impaired, ion channels
|
351: Increased Mortality
|
|
|
| 105 |
Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) |
Charles Wood |
BY-SA |
714: Increased, Binding of chemicals to 2u (serum)
|
713: Increase, Adenomas/carcinomas (renal tubular)
|
|
|
| 108 |
Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
724: Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme
|
719: Increase, hepatocellular adenomas and carcinomas
|
|
|
| 71 |
Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation |
Undefined |
BY-SA |
650: Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid
|
520: Decreased sperm quantity or quality in the adult, Decreased fertility
|
|
|
| 28 |
Cyclooxygenase inhibition leading reproductive failure |
Dan Villeneuve |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
253: N/A, Reproductive failure
|
|
|
| 29 |
Estrogen receptor agonism leading to reproductive dysfunction |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
4 AOs
|
|
|
| 36 |
Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis |
Michelle Angrish |
BY-SA |
3 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 52 |
ER agonism leading to skewed sex ratios due to altered sexual differentiation in males |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
417: skewed, sex ratio
|
|
|
| 53 |
ER agonism leading to reduced survival due to renal failure |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
None
|
|
|
| 57 |
AhR activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
18: Activation, AhR
|
459: Increase, Liver steatosis
|
|
|
| 58 |
NR1I3 (CAR) suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
4 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 59 |
HNF4alpha suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
461: Suppression, HNF4alpha
|
None
|
|
|
| 60 |
NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
245: Activation, PXR/SXR
|
459: Increase, Liver steatosis
|
|
|
| 62 |
AKT2 activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
486: systemic inflammation leading to hepatic steatosis
|
459: Increase, Liver steatosis
|
|
|
| 63 |
Cyclooxygenase inhibition leading to reproductive dysfunction |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 64 |
Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility |
Undefined |
BY-SA |
494: Glucocorticoid Receptor Agonist, Activation
|
406: decreased, Fertility
|
|
|
| 66 |
Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 67 |
Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|